Dr. Yarmush is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 Blossom Street
Room 405
Boston, MA 02114Phone+1 617-726-3474
Summary
- Martin Yarmush, MD is a highly educated and experienced professional in the field of research, based in Boston, MA and Piscataway, NJ. He attained his BA in Biology, and minor in Chemistry, Summa Cum Laude from Yeshiva University, before completing two PhDs in Biophysical Chemistry, Immunology from Rockefeller University, and Chemical Engineering from Massachusetts Institute of Technology (MIT). Dr. Yarmush holds several positions concurrently, including, amongst others, the Director of the Center for Engineering in Medicine and Surgery at the Massachusetts General Hospital, the Paul and Mary Monroe Endowed Chair and Distinguished Professor of Biomedical Engineering at Rutgers University, and Senior Scientist at Shriners Children's in Boston. He has produced >500 notable publications, cited tens of thousands of times, in fields from wound care to biotech, and bioengineering to medical devices.
Education & Training
- Massachusetts Institute of TechnologyPhD Studies, Chemical Engineering, 1982 - 1984
- Yale School of MedicineClass of 1983
- Rockefeller UniversityPhD, Biophysical Chemistry, Immunology, 1975 - 1979
- Yeshiva UniversityBA, Biology; Chemistry Minor, Summa Cum Laude, 1971 - 1975
Publications & Presentations
PubMed
- 5 citationsMultifunctional Elastin-like Polypeptide Fusion Protein Coacervates Inhibit Receptor-mediated Pro-inflammatory Signals and Promote Angiogenesis in Mouse Diabetic Wounds.Hwan June Kang, Suneel Kumar, Biraja C. Dash, Henry C. Hsia, Martin L. Yarmush
Advances in Wound Care. 2021-11-13 - HSymM-guided engineering of the immunodominant p53 transactivation domain putative peptide antigen for improved binding to its anti-p53 monoclonal antibody.Zachary Fritz, Rene S. Schloss, Martin L. Yarmush, Lawrence J. Williams
Bioorganic & Medicinal Chemistry Letters. 2021-11-01 - 28 citationsAutofluorescence of blood and its application in biomedical and clinical research.Anil B. Shrirao, Rene S. Schloss, Zachary Fritz, Mayur V. Shrirao, Robert T. Rosen
Biotechnology and Bioengineering. 2021-09-06
Press Mentions
- A Major Research Project to Advance Regenerative Therapy for Epidermolysis Bullosa (EB) Using Transgenic Stem CellsNovember 1st, 2021
- Better ‘Biobanking’ Could Pay off for Organ RecipientsSeptember 9th, 2021
- Someday, a Robot Might Draw Your BloodJune 15th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: